Business · 1 sources covering this

Gujarat Themis secures $58 million private credit for Japanese acquisition

Founded in 1981, Gujarat Themis is India's first company to start commercial production of the anti-tuberculosis drug Rifampicin, according to its website

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Gujarat Themis secures $58 million private credit for Japanese acquisition
Founded in 1981, Gujarat Themis is India's first company to start commercial production of the anti-tuberculosis drug Rifampicin, according to its website
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/71447a8105df51e99f80f8e0b511f343f2912a95"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Gujarat Themis secures $58 million private credit for Japanese acquisition"></iframe>

Gujarat Themis secures $58 million private credit for Japanese acquisition

How 1 sources are covering this

Gujarat Themis secures $58 million private credit for Japanese acquisition

More from Business

US-Iran war: Trump rejects report that US will offer Tehran ‘sanctions relief’; Araghchi meets mediators | Top Updates

Indian IT vendor jailed in Singapore for 28 weeks over data breach

Coforge appoints Akhil Gupta as independent chairperson for five years

Delhi set to get warmer after rainy, unusually cool Monday; dry spell ahead

Reader

Trust & legal

Across the network